the Ibogaine Community Worldwide - User to User

7/31/2019 the Ibogaine Community Worldwide - User to User

1/36

Ibogaine Community

WorldwideUser-to-User

BrugerForeningenInternational Drug Users Day

(IDUD) 2008

Copenhagen, Denmark

31 October - 3 November 2008

Howard S. LotsofDora Weiner Foundation

Staten Island, NY


2/36

Ibogaine Found in the West

African plant Tabernantheiboga


3/36

Iboga alkaloids are concentrated

in the bark of the root


4/36

Usable forms include scrapedor ground root bark


5/36


6/36


7/36

Regulatory and Scientific

Development

The first attempt at drug development of ibogaine wasby the Dora Weiner Foundation in 1983.

In 1986, a for-profit corporation, NDA International,Inc. was established and subsequently raised 4 million

towards the approval of ibogaine, initiating researchand patent development.

1991, National Institute on Drug Abuse ibogaineresearch project.

1993, FDA approval for University of Miami clinicalstudy.


8/36

Ibogaine Patents

1. Rapid method for interrupting the narcoticaddiction syndrome, US 4,499,096 (1985)

2. Rapid method for interrupting the cocaine andamphetamine abuse syndrome US 4,587,243(1986)

3. Rapid method for attenuating the alcoholdependency syndrome, US 4,957,523 (1989)

4. Rapid method for interrupting or attenuating thenicotine/tobacco dependency syndrome, US5,026,697 (1991)

5. Rapid method for interrupting or attenuating poly-drug dependency syndromes, US 5, 124,994(1992)


9/36

First scientific publication of

ibogaine antiaddictive effects


10/36

Ibogaine effects on

Morphine self-administration

(Glick et al. 1991)


11/36

Ibogaine effects on

Morphine withdrawal

(Glick et al. 1992)


12/36

Ibogaine effects on cocaine(Cappendijk & Dzoljic. 1993)


13/36

Ibogaine effects on alcohol

(Rezvani et al. 1995)


14/36


15/36

Ibogaine:Stages of effect

1. Visualization or wakingdream-like experience

3 - 6 hours

2. Cognitive evaluation8 - 20 hours

3. Residual stimulation

12 - 72 hours


16/36

Ibogaine:Side-effects

1. Nausea or vomiting

2. Ataxia


17/36

1. Ibogaine significantly reduces withdrawal

2. Interrupts drug craving

3. Interrupts drug self-administration

4. Returning patients to a preaddictive state

5. Antibacterial

6. Returns free choice

7. Eliminates stigma


18/36

Ibogaine

1) User discovered

2) User developed

3) User supported


19/36

Ibogaine ActivistAdvocacy Organizations Play

Role in Ibogaine Development

International Coalition for Addict Self-Help(ICASH) 1989

Dutch Addict Self-Help (DASH) 1990

International Addict Self-Help (INTASH) 1992

Cures-Not Wars (ibogaine and other issues) 1994

Ibogaine Underground 2004


20/36

ICASH logo

Used to attract attention of government

officials and media


21/36


22/36


23/36

Cures-Not-Wars placed pressureon NIDA to support Ibogaine

research through protests


24/36

Mindvox internet ibogaine list

(user advocacy continues)

We all got to help each other best we can. No

one else gives a shit bout us hippy freak

junkies? anon.

To join send an email to

[email protected]


25/36

FM- We feel that continuing the focusoffshore, outside the US, has not served amajority of people inside the US. Like manyother grassroots movements, which facilitated

change, treatments, sessions, need to be donewhere they belong, in all major US cities, ascost effectively as possible.

http://www.drugwar.com/ibonyc.shtm

Ibogaine underground appears 2004


26/36

Ibogaine:

Question #1asked by users


27/36


28/36

Ibogaine & Withdrawal


29/36

Ibogaine & Withdrawal- Early findings ca. 1995 -

http://ibogaine.org/ibonarco.htm


30/36

1. While ibogaine effects may be generalized,they are also specific to each individual.

2. Each person treated and each experience hasunique characteristics that must be observedand responded to uniquely.

3. The administration of ibogaine requires, art,craft and practice as do all human endeavor.

Technology Transfer


31/36

a growing problem

1. United States 1967

2. Belgium 1987

3. Switzerland 1989

4. Sweden 1999

5. Denmark 2003

6. France 2007


32/36

1. Ibogaine significantly reduces opioidwithdrawal to heroin, methadone andother narcotics

2. Interrupts drug craving3. Returns users to a preaddictive state

4. Eliminates stigma

5. Offers freedom of choice


33/36

HRC

1. Initially skeptical

2. Observed ibogaine proponents in their system

3. Now supports and refers to treatmentIHRA

1. Skeptical

2. No observation of treated persons

3. Education and treatment observations

required


34/36


35/36


36/36

the Ibogaine Community Worldwide - User to User

Documents

Transcript of the Ibogaine Community Worldwide - User to User